LENZ Therapeutics, Inc. (LENZ)
USD 20.81
(-9.52%)
USD 20.81
(-9.52%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -185.49 Million USD | -342.34% |
| 2022 | -41.93 Million USD | 88.88% |
| 2021 | -376.97 Million USD | -1802.29% |
| 2020 | -19.81 Million USD | -1001.18% |
| 2019 | 2.19 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -199.76 Million USD | -7.69% |
| 2024 Q2 | -82.44 Million USD | 58.73% |
| 2023 FY | -185.49 Million USD | -342.34% |
| 2023 Q2 | -74.96 Million USD | -14.85% |
| 2023 Q1 | -65.27 Million USD | -55.64% |
| 2023 Q4 | -185.49 Million USD | -42.83% |
| 2023 Q3 | -129.87 Million USD | -73.25% |
| 2022 FY | -41.93 Million USD | 88.88% |
| 2022 Q4 | -41.93 Million USD | 15.08% |
| 2022 Q3 | -49.38 Million USD | 26.27% |
| 2022 Q2 | -66.98 Million USD | 61.7% |
| 2022 Q1 | -174.89 Million USD | 53.61% |
| 2021 Q2 | -382.11 Million USD | 0.0% |
| 2021 FY | -376.97 Million USD | -1802.29% |
| 2021 Q4 | -376.97 Million USD | 2.2% |
| 2021 Q3 | -385.46 Million USD | -0.88% |
| 2020 FY | -19.81 Million USD | -1001.18% |
| 2019 FY | 2.19 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -231.604% |
| Alkermes plc | -166.73 Million USD | -11.251% |
| Agenus Inc. | 274.13 Million USD | 167.667% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 109.92% |
| Aptorum Group Limited | 1.35 Million USD | 13769.323% |
| Ardelyx, Inc. | 34.51 Million USD | 637.491% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4434.089% |
| Bicycle Therapeutics plc | -481.46 Million USD | 61.472% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 612.952% |
| ChromaDex Corporation | -24.04 Million USD | -671.37% |
| Chimerix, Inc. | -25.51 Million USD | -626.962% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2762.127% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -683.457% |
| CRISPR Therapeutics AG | -150.84 Million USD | -22.973% |
| Precision BioSciences, Inc. | -85.41 Million USD | -117.187% |
| Dyadic International, Inc. | -6.37 Million USD | -2808.374% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1064.244% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2520.078% |
| Lantern Pharma Inc. | -21.7 Million USD | -754.705% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -67.816% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2071.312% |
| Incyte Corporation | -3.17 Billion USD | 94.158% |
| IO Biotech, Inc. | -140.69 Million USD | -31.841% |
| Jaguar Health, Inc. | 29.39 Million USD | 731.142% |
| Novavax, Inc. | -298.29 Million USD | 37.813% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3575.717% |
| Opthea Limited | 28.15 Million USD | 758.792% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1004.884% |
| ContextLogic Inc. | -232 Million USD | 20.044% |
| MiMedx Group, Inc. | -33.9 Million USD | -447.179% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1919.51% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7905.906% |
| NextCure, Inc. | -6.47 Million USD | -2763.965% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -267.317% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2807.964% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1625.075% |
| Vaxcyte, Inc. | -368.22 Million USD | 49.624% |
| PDS Biotechnology Corporation | -32.7 Million USD | -467.121% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1173.614% |
| Pharming Group N.V. | 109.8 Million USD | 268.936% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -966.331% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -5.86% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -901.622% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -901.622% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2512.662% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3065.512% |
| Acelyrin, Inc. | -216.9 Million USD | 14.478% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3206.42% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -10659.803% |
| Summit Therapeutics Inc. | 34.67 Million USD | 634.98% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2626.724% |
| Senti Biosciences, Inc. | 1.74 Million USD | 10760.862% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -0.483% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -139.505% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2960.03% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 186028.495% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 29638.057% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -58.484% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -10.263% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 267.312% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2342.062% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -43.671% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2790.498% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 23.462% |
| Immix Biopharma, Inc. | -17.5 Million USD | -959.402% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 41.428% |
| MEI Pharma, Inc. | -3.7 Million USD | -4906.721% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1582.687% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 214.688% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 767.431% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2520.078% |
| Precigen, Inc. | -481 Thousand USD | -38465.281% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1417.371% |
| AlloVir, Inc. | -62.69 Million USD | -195.889% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -233.547% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 400.812% |
| ImmuCell Corporation | 10.99 Million USD | 1787.803% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -20.34% |
| Onconetix, Inc. | 5.33 Million USD | 3579.343% |
| PureTech Health plc | -167.19 Million USD | -10.946% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -508.992% |
| Elevation Oncology, Inc. | -19.11 Million USD | -870.285% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3678.753% |
| Seer, Inc. | -4.24 Million USD | -4274.976% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -671.723% |
| Innoviva, Inc. | 255.56 Million USD | 172.584% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -232.055% |
| ESSA Pharma Inc. | -33.62 Million USD | -451.726% |
| GlycoMimetics, Inc. | -40.98 Million USD | -352.608% |
| GT Biopharma, Inc. | -1.02 Million USD | -18068.364% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -173.666% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 402.821% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -38.351% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1238.763% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -542.488% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -246135.432% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -501.06% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2163.603% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5828.346% |
| Soligenix, Inc. | -4.95 Million USD | -3646.246% |
| Century Therapeutics, Inc. | 847 Thousand USD | 22000.708% |
| Kura Oncology, Inc. | -20.11 Million USD | -822.055% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -353.255% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2108.847% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 10282.769% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5702.283% |
| Autolus Therapeutics plc | -186.59 Million USD | 0.589% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -276.235% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 32.74% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 641.318% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 212.856% |
| GRI Bio, Inc. | -1.79 Million USD | -10239.967% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1964.99% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -457.774% |
| IGM Biosciences, Inc. | -72.6 Million USD | -155.487% |
| INmune Bio, Inc. | -25.41 Million USD | -629.995% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 222.887% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -266.172% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1041.576% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6329.94% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 587.963% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -350.404% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 681.775% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 149.08% |
| Verastem, Inc. | -37.27 Million USD | -397.61% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1944.517% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -257.678% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1125.629% |
| Histogen Inc. | -7.48 Million USD | -2377.615% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -758.521% |
| Surrozen, Inc. | -32.66 Million USD | -467.9% |
| Organovo Holdings, Inc. | -1.5 Million USD | -12209.157% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4312.978% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1078.36% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 7190.94% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4563.402% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2113.288% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -327.004% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1172.558% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 41.444% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -25590.247% |
| Apollomics, Inc. | -27.39 Million USD | -577.127% |
| Amarin Corporation plc | -191.04 Million USD | 2.9% |
| Mesoblast Limited | 55.96 Million USD | 431.467% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1171.935% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -633.43% |
| Synaptogenix, Inc. | -28.66 Million USD | -547.206% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -19718.269% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 480.651% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -21417.384% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2452.945% |
| Exelixis, Inc. | -73.05 Million USD | -153.934% |
| Better Therapeutics, Inc. | -860 Thousand USD | -21469.651% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -672.494% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 23.148% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 25301.409% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2393.891% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 14892.584% |
| Gritstone bio, Inc. | 39.49 Million USD | 569.737% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -120.567% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6947.459% |
| Avid Bioservices, Inc. | 169.72 Million USD | 209.292% |
| Insmed Incorporated | 721.62 Million USD | 125.706% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1929.194% |
| MediWound Ltd. | -5.32 Million USD | -3385.513% |
| OmniAb, Inc. | 9.2 Million USD | 2115.636% |
| Alector, Inc. | -35.63 Million USD | -420.524% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 315.769% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3664.184% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1501.156% |
| Zai Lab Limited | -775 Million USD | 76.065% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 154.47% |
| Aura Biosciences, Inc. | -21.52 Million USD | -761.784% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -124.902% |
| Immunic, Inc. | -45.34 Million USD | -309.129% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 3.993% |
| Veracyte, Inc. | -203.82 Million USD | 8.991% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 129.062% |
| FibroGen, Inc. | 56.76 Million USD | 426.773% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2183.088% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6461.501% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -8859.798% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.041% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5452.2% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -11.771% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1138.512% |
| Galecto, Inc. | -21.21 Million USD | -774.335% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -679.899% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 111.82% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -658.005% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1512.054% |
| XBiotech Inc. | -200.02 Million USD | 7.261% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -120.567% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4196.709% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -426.044% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -140.228% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3359.515% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -8.851% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -100.813% |
| Vaxxinity, Inc. | 10.13 Million USD | 1930.823% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 125.195% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1622.759% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -181.247% |
| NexImmune, Inc. | -3.13 Million USD | -5819.596% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5272.62% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1127.539% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -584.498% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1966.599% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -148805.479% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -357.209% |
| Ainos, Inc. | 4.07 Million USD | 4648.854% |
| Pluri Inc. | 22.82 Million USD | 912.559% |
| Prothena Corporation plc | -608.34 Million USD | 69.508% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -56.202% |
| Celularity Inc. | 65.19 Million USD | 384.551% |
| Rallybio Corporation | -24.1 Million USD | -669.642% |
| Cue Biopharma, Inc. | -33.81 Million USD | -448.505% |
| MeiraGTx Holdings plc | -40.3 Million USD | -360.272% |
| Omeros Corporation | 331.17 Million USD | 156.012% |
| Humacyte, Inc. | -22.48 Million USD | -724.953% |
| Immunocore Holdings plc | -358.59 Million USD | 48.27% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -654.828% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -500.301% |
| Blueprint Medicines Corporation | 702.83 Million USD | 126.393% |
| CalciMedica, Inc. | -5.53 Million USD | -3254.412% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 1.446% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1716.125% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -363.319% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -457.841% |
| Pulmatrix, Inc. | -10.41 Million USD | -1680.733% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3003.547% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -386.338% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -66.513% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -209.454% |
| Cytokinetics, Incorporated | 642.37 Million USD | 128.877% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3085.626% |
| Nutriband Inc. | -251.65 Thousand USD | -73611.043% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -443.682% |
| Vor Biopharma Inc. | 4.3 Million USD | 4413.93% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.927% |
| Evogene Ltd. | -19.63 Million USD | -844.785% |
| ProKidney Corp. | -56.23 Million USD | -229.858% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -281.121% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1908.176% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 113.601% |
| CorMedix Inc. | -43.05 Million USD | -330.867% |
| BioLineRx Ltd. | 7.33 Million USD | 2628.612% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -575.401% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 501.974% |
| Atai Life Sciences N.V. | -28.55 Million USD | -549.552% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 8416.368% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -713.022% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1145.949% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -147.088% |
| MediciNova, Inc. | -50.78 Million USD | -265.274% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -135.39% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -824523.25% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2774.8% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 7.167% |
| Biomea Fusion, Inc. | -166.57 Million USD | -11.364% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -3.645% |
| Mereo BioPharma Group plc | -51.46 Million USD | -260.409% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -95.583% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 36.853% |
| Absci Corporation | -72.59 Million USD | -155.515% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4162.615% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 20.875% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -96.897% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -93.842% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -374.75% |
| Allakos Inc. | -24.97 Million USD | -642.739% |
| Imunon, Inc. | -4.21 Million USD | -4302.124% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1158.303% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -37.001% |
| BioAtla, Inc. | -109.01 Million USD | -70.165% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 25301.409% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -19654.952% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1650.217% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -774.871% |
| XOMA Corporation | -29 Million USD | -539.652% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1020.163% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1957.442% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2390.254% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -48.833% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 10.888% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -126.83% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -99.971% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -21490.137% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4724.421% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11530.165% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 113.433% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -15512.62% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4324.527% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 263.463% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 257873.547% |
| Orgenesis Inc. | 21.78 Million USD | 951.538% |
| Entera Bio Ltd. | -10.62 Million USD | -1645.216% |
| GH Research PLC | -78.07 Million USD | -137.585% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -732.282% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -595.821% |
| Xencor, Inc. | 29.64 Million USD | 725.756% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -9317.092% |
| Replimune Group, Inc. | 1.41 Million USD | 13237.323% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -75642.32% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -46.736% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -15512.62% |
| Portage Biotech Inc. | -4.98 Million USD | -3624.132% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -824523.25% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -180.541% |
| OncoCyte Corporation | -6.56 Million USD | -2726.436% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 20770.416% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3971.851% |
| Purple Biotech Ltd. | -14.13 Million USD | -1212.06% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -680.851% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2734.209% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1011.294% |
| HilleVax, Inc. | -165.48 Million USD | -12.094% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7208.865% |
| Tharimmune, Inc. | -10.93 Million USD | -1596.324% |
| Genprex, Inc. | -6.73 Million USD | -2653.179% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 49.703% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -109.698% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -13140.471% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5492.464% |
| OKYO Pharma Limited | -826.84 Thousand USD | -22334.474% |
| Savara Inc. | 153 Thousand USD | 121341.176% |
| Curis, Inc. | -23.88 Million USD | -676.569% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3496.398% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -23804.141% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2888.064% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 15753.924% |
| BeiGene, Ltd. | -2.25 Billion USD | 91.767% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1603.416% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 69.501% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 0.047% |
| Erasca, Inc. | -37.21 Million USD | -398.439% |
| bluebird bio, Inc. | 108.57 Million USD | 270.855% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14303.293% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 148.977% |
| DBV Technologies S.A. | -126.98 Million USD | -46.078% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14303.293% |
| Moderna, Inc. | -2.9 Billion USD | 93.619% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1691.915% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1606.837% |
| Molecular Templates, Inc. | 707 Thousand USD | 26337.482% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -491.307% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 153.518% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -126.047% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -102.223% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -474.799% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -439.618% |
| MacroGenics, Inc. | -66.98 Million USD | -176.926% |
| RenovoRx, Inc. | -1.17 Million USD | -15714.066% |
| Adicet Bio, Inc. | -138.78 Million USD | -33.657% |
| Prime Medicine, Inc. | -27.94 Million USD | -563.895% |
| Aditxt, Inc. | 18.12 Million USD | 1123.675% |
| Adagene Inc. | -87.62 Million USD | -111.691% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4353.3% |
| Quantum-Si incorporated | -118.55 Million USD | -56.464% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 615.203% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2381.862% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -282.401% |
| SciSparc Ltd. | -2.06 Million USD | -8883.002% |
| Vericel Corporation | 1.27 Million USD | 14626.155% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1446.895% |
| Minerva Neurosciences, Inc. | 41 Million USD | 552.39% |
| Generation Bio Co. | 31.44 Million USD | 689.859% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -5.779% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -499.874% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 259.1% |
| Invivyd, Inc. | -198.47 Million USD | 6.538% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -105.494% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7636.577% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -162.041% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2617.934% |
| 2seventy bio, Inc. | 181.71 Million USD | 202.082% |
| ADMA Biologics, Inc. | 90.06 Million USD | 305.959% |
| Clene Inc. | 3.34 Million USD | 5653.862% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1942.333% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -762.345% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2774.8% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 46.095% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -613.466% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 204.409% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4433.691% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3808.497% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3461.125% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -42.359% |
| Evaxion Biotech A/S | 5.28 Million USD | 3608.691% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -64.788% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -41.308% |
| Trevena, Inc. | 2.25 Million USD | 8315.19% |
| Surrozen, Inc. | -32.66 Million USD | -467.9% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -260.122% |
| Cingulate Inc. | 3.08 Million USD | 6117.453% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6215.935% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2681.035% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1896.496% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -133.853% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -41.115% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -75.758% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4604.947% |
| Kronos Bio, Inc. | -36.05 Million USD | -414.503% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2071.506% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 12821.731% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -241.896% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1386.722% |
| ImmunityBio, Inc. | 618.22 Million USD | 130.005% |
| Korro Bio, Inc. | -132.94 Million USD | -39.533% |
| Kineta, Inc. | -4.54 Million USD | -3984.981% |
| BioVie Inc. | -17.73 Million USD | -946.105% |
| Codexis, Inc. | -43.27 Million USD | -328.691% |
| Celularity Inc. | 65.19 Million USD | 384.551% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5753.55% |
| Celcuity Inc. | 6.78 Million USD | 2834.558% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5412.692% |
| Cibus, Inc. | -8.07 Million USD | -2196.348% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4286.356% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4159.059% |
| IN8bio, Inc. | -16.38 Million USD | -1031.851% |
| Kodiak Sciences Inc. | -103.87 Million USD | -78.579% |
| Annexon, Inc. | -193.75 Million USD | 4.261% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 515375.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -960.055% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5180.359% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 117.595% |
| Eyenovia, Inc. | 1.25 Million USD | 14837.325% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 789.459% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5619.981% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -457.942% |
| Arcellx, Inc. | -296.95 Million USD | 37.534% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -850.984% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -215.073% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -794.963% |
| Moolec Science SA | 117.61 Thousand USD | 157815.787% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -383.083% |
| Geron Corporation | 14.76 Million USD | 1356.683% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -389.211% |
| Royalty Pharma plc | 5.65 Billion USD | 103.278% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -31.168% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2553.996% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3358.957% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -31.811% |
| Humacyte, Inc. | -22.48 Million USD | -724.953% |
| Structure Therapeutics Inc. | -124.33 Million USD | -49.188% |
| 89bio, Inc. | -289.05 Million USD | 35.825% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -634.882% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -10303.758% |
| Genelux Corporation | -6.89 Million USD | -2588.781% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -497.247% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 321.891% |
| Notable Labs, Ltd. | -9.77 Million USD | -1797.494% |
| Liquidia Corporation | -80.17 Million USD | -131.365% |
| Mustang Bio, Inc. | -3.73 Million USD | -4865.177% |
| Immunovant, Inc. | -635.22 Million USD | 70.798% |
| Quantum-Si incorporated | -118.55 Million USD | -56.464% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -956.132% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4377.408% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2410.938% |
| Acasti Pharma Inc. | -23 Million USD | -706.342% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5408.951% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1041.576% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -34.673% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5852.421% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -734.378% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -898.971% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -9.582% |
| PepGen Inc. | -60.67 Million USD | -205.751% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -707.36% |
| United Therapeutics Corporation | -507.7 Million USD | 63.463% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -869.879% |
| Solid Biosciences Inc. | -47.75 Million USD | -288.48% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -21417.384% |
| Immuneering Corporation | -54.94 Million USD | -237.622% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4312.978% |
| Silo Pharma, Inc. | -3.52 Million USD | -5163.416% |
| Belite Bio, Inc | -87.27 Million USD | -112.555% |
| XOMA Corporation | -29 Million USD | -539.652% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -162.386% |
| Bionomics Limited | 227 Million USD | 181.714% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -59.525% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7223.293% |
| uniQure N.V. | -102.95 Million USD | -80.182% |
| Cassava Sciences, Inc. | -121.13 Million USD | -53.133% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4353.3% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 552.978% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1450.865% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5895.055% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 175099.057% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5619.981% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2183.088% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2401.335% |
| Altimmune, Inc. | -134.48 Million USD | -37.931% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 193.656% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7223.293% |
| Compugen Ltd. | -12.9 Million USD | -1337.531% |
| Peak Bio, Inc. | 10.34 Million USD | 1893.967% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -65447.35% |
| Benitec Biopharma Inc. | -50.58 Million USD | -266.729% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -77.787% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1044.256% |
| Zura Bio Limited | -99.8 Million USD | -85.86% |
| PolyPid Ltd. | 6.17 Million USD | 3106.467% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 350.268% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1044.256% |
| Instil Bio, Inc. | 75.35 Million USD | 346.157% |
| argenx SE | -2.02 Billion USD | 90.857% |
| Immunome, Inc. | -97.02 Million USD | -91.179% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -724.623% |
| Verona Pharma plc | -220.44 Million USD | 15.852% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -158.56% |
| Shattuck Labs, Inc. | -121.42 Million USD | -52.77% |
| CervoMed Inc. | -7.79 Million USD | -2280.376% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4141.916% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -40.807% |
| Moolec Science SA | 117.61 Thousand USD | 157815.787% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8007.555% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1266.779% |
| AnaptysBio, Inc. | -18.15 Million USD | -921.977% |
| Design Therapeutics, Inc. | -18.15 Million USD | -922.033% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -163.564% |
| NeurAxis, Inc. | 145.7 Thousand USD | 127415.717% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1751.522% |
| Lumos Pharma, Inc. | -28.49 Million USD | -551.034% |
| Achilles Therapeutics plc | -126.92 Million USD | -46.15% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -158.56% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -28188.93% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -792.946% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 12821.731% |
| Nutriband Inc. | -251.65 Thousand USD | -73611.043% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1308.39% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2393.266% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 154.527% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 881.542% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 58.545% |
| Palisade Bio, Inc. | -12.06 Million USD | -1437.752% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -32.206% |
| Beam Therapeutics Inc. | -262.72 Million USD | 29.393% |
| Neurogene Inc. | -131.95 Million USD | -40.577% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 950.289% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3701.209% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 50.821% |
| Sesen Bio, Inc. | -112.55 Million USD | -64.81% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -85.759% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7800.995% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -375.322% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -122.736% |
| Athira Pharma, Inc. | -88.99 Million USD | -108.428% |
| Vaccinex, Inc. | -1.28 Million USD | -14302.096% |
| HCW Biologics Inc. | 2.85 Million USD | 6593.526% |
| XOMA Corporation | -29 Million USD | -539.652% |
| Nektar Therapeutics | 210.24 Million USD | 188.232% |
| Arvinas, Inc. | -313.8 Million USD | 40.886% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11530.165% |
| Merus N.V. | -192.88 Million USD | 3.829% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 409.242% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2573.667% |
| Rezolute, Inc. | -68.16 Million USD | -172.12% |
| Clene Inc. | 3.34 Million USD | 5653.862% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1306.681% |
| BeyondSpring Inc. | -13.75 Million USD | -1248.593% |
| Synlogic, Inc. | -6.68 Million USD | -2674.854% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 16457.937% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2093.956% |
| Peak Bio, Inc. | 10.34 Million USD | 1893.967% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -125.066% |
| Krystal Biotech, Inc. | -350.23 Million USD | 47.036% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 249.445% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -9.765% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5775.532% |
| MannKind Corporation | 143.89 Million USD | 228.909% |
| Ikena Oncology, Inc. | -109.15 Million USD | -69.939% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2350.125% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -460.42% |
| Gossamer Bio, Inc. | 180.35 Million USD | 202.852% |
| CohBar, Inc. | -5.93 Million USD | -3027.759% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -523.568% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4162.615% |
| Legend Biotech Corporation | -949.39 Million USD | 80.461% |
| Mural Oncology plc | -255.84 Million USD | 27.495% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 675.816% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3837.871% |
| Disc Medicine, Inc. | -358.28 Million USD | 48.225% |
| Champions Oncology, Inc. | 4.81 Million USD | 3954.925% |
| REGENXBIO Inc. | 54.76 Million USD | 438.7% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -68882.585% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -22.827% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1958.354% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -129.911% |
| Vaxart, Inc. | -8.24 Million USD | -2150.928% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -269.667% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -45.872% |
| Cellectis S.A. | -43.85 Million USD | -322.983% |
| Longeveron Inc. | -2.9 Million USD | -6278.92% |
| Repare Therapeutics Inc. | -107.85 Million USD | -71.984% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 119.156% |
| Inozyme Pharma, Inc. | 12 Million USD | 1645.31% |
| Revolution Medicines, Inc. | -608.2 Million USD | 69.501% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -14981.22% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 30.031% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -23.607% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1085.524% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -24967.432% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.06% |
| Denali Therapeutics Inc. | -74.86 Million USD | -147.778% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1446.895% |
| Veru Inc. | 4.77 Million USD | 3980.757% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1549.466% |
| Cingulate Inc. | 3.08 Million USD | 6117.453% |
| Passage Bio, Inc. | 4.58 Million USD | 4145.78% |
| Context Therapeutics Inc. | -14.44 Million USD | -1183.745% |
| Exicure, Inc. | 5.84 Million USD | 3271.465% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 19.48% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -368.787% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1282.2% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -215.362% |
| Nuvalent, Inc. | -335.38 Million USD | 44.691% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 10795.648% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -149.052% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1986.603% |
| OmniAb, Inc. | 9.2 Million USD | 2115.636% |
| Anew Medical, Inc. | 1.43 Million USD | 13049.636% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1232.351% |
| Lipocine Inc. | -4.75 Million USD | -3801.47% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -68.9% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1317.904% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -266.172% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 845.215% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2659.991% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -181.798% |
| Ocugen, Inc. | -32.52 Million USD | -470.398% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -116.768% |
| Q32 Bio Inc. | -37.94 Million USD | -388.824% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -29438.057% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1271.121% |
| Equillium, Inc. | -22.39 Million USD | -728.416% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -625.512% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -468.548% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -74723.629% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 238.389% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5900.469% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 56578.637% |
| Dominari Holdings Inc. | 195 Thousand USD | 95227.692% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3421.97% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1980.285% |
| Bio-Techne Corporation | 267.74 Million USD | 169.281% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1044.42% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -57.077% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2107.533% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1366.279% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 24.323% |
| Nkarta, Inc. | 57.29 Million USD | 423.739% |
| BioCardia, Inc. | 212 Thousand USD | 87599.528% |
| Iterum Therapeutics plc | 13.43 Million USD | 1480.406% |